Endometrial cancer, originating from the lining of the uterus, is one of the most common gynecologic malignancies. As with many cancers, accurate staging is crucial for determining the appropriate treatment and predicting outcomes. Traditionally, this has involved extensive lymph node dissection, which, while effective for staging, carries significant risks and potential complications. Enter the sentinel lymph node (SLN) biopsy—a technique that offers a less invasive yet more informative approach to staging endometrial cancer.
Understanding Sentinel Lymph Node Biopsy
The concept of the sentinel lymph node is based on the theory that cancer cells spread in an orderly fashion from the primary tumor to the first draining lymph node, or group of nodes, before moving to others. By identifying and examining these sentinel nodes, we can determine whether cancer has metastasized without needing to remove numerous lymph nodes.
In endometrial cancer, SLN biopsy involves injecting a tracer substance (indocyanine green- ICG dye) in the cervix. This tracer travels the same lymphatic pathways that cancer cells would, highlighting the sentinel nodes. Surgeons can then remove these nodes for pathological examination.
Advantages of SLN Biopsy
- Minimally Invasive: Compared to traditional lymphadenectomy, which can involve the removal of numerous lymph nodes, SLN biopsy is less extensive, reducing surgical time and recovery.
- Reduced Morbidity: Traditional lymph node dissection can lead to complications like lymphedema (swelling due to lymph fluid), nerve injury, and vascular damage. SLN biopsy significantly lowers these risks.
- Accurate Staging: Studies have shown that SLN biopsy provides reliable information for staging endometrial cancer. If sentinel nodes are free of cancer, it’s highly likely that the cancer has not spread to other nodes.
- Targeted Pathology: Pathologists can perform more detailed examinations on a smaller number of nodes, increasing the chances of detecting microscopic metastases and even isolated tumour cells.
The Procedure
- Injection of Dye: Before surgery,ICG dye is injected in the cervix at 3 and 9 o’clock positions.
- Identification of Sentinel Nodes: Using a special mode - Firefly on the Da Vinci robot, surgeons identify the sentinel nodes.
- Removal and Examination: These nodes are then surgically removed and sent to a pathologist for detailed examination. If cancer cells are found, further treatment such as additional lymph node removal, radiation, or chemotherapy may be necessary.
SLN Biopsy in Clinical Practice
The adoption of SLN biopsy in endometrial cancer has been growing, supported by guidelines from prominent medical organizations. For instance, the National Comprehensive Cancer Network (NCCN) includes SLN biopsy as an option for staging in early-stage endometrial cancer.
Challenges and Considerations
While SLN biopsy offers many benefits, it’s not without challenges. Accurate identification of sentinel nodes requires expertise and experience. It is a must that a surgeon and the centre in which this is being performed has enough experience.
We provide these services with a high level of expertise by offering robotic hysterectomy surgery in Delhi for endometrial cancer with facilities of sentinel lymph node biopsy.
We have been doing this for many years with some publications in peer-reviewed journal - https://link.springer.com/article/10.1007/s40944-019-0262-9
False negatives, where sentinel nodes appear cancer-free despite the presence of cancer in other lymph nodes, are a concern, though rare with proper technique and experience.
Conclusion
Sentinel lymph node biopsy represents a significant advancement in the staging and treatment of endometrial cancer. By providing accurate staging with fewer complications, it empowers clinicians to tailor treatments more effectively and improve patients’ quality of life. As expertise grows and technology advances, SLN biopsy will has now become standard component of endometrial cancer care globally, epitomizing the shift towards more precise and patient-friendly oncology practices.